Tricuspid repair firm 4Tech taps ex-Boston Scientific execs for CEO, CMO | Personnel Moves for Feb. 27, 2018
4Tech said last week that it named a pair of BSX veterans as its new CEO and CMO, with onetime chief Mike Ennen stepping away for “family reasons.”
Galway, Ireland-based 4Tech said former Boston transcatheter aortic valve GM Tom Fleming is slated to take the reins from Thoratec vet Ennen as president & CEO in March. The company, which is developing the TriClinch Coil transcatheter tricuspid valve repair device, also said that Dr. Keith Dawkins, Boston’s ex-global medical chief, was named CMO effective Feb. 22.
Z-Medica lures ex-Hologic COO Compton
Z-Medica said it named former Hologic (NSDQ:HOLX) COO Eric Compton to be its new president & CEO, replacing Stephen Fanning, who is stepping down "to pursue a new career opportunity that will allow him to be closer to his family and home on the West Coast," the hemostat company said.
Read more
Check-Cap promotes COO Ovadia to CEO
Check-Cap (NSDQ:CHEK) promoted Alex Ovadia from COO and R&D VP to CEO, succeeding Bill Densel, "who will provide support to complete a seamless transition," the company said.
Read more
Invacare makes it official with interim CFO Leneghan
Invacare (NYSE:IVC) made it official with interim CFO Kathleen Leneghan, naming her SVP and finance chief effective Feb. 22. Leneghan took over last November, when former CFO Robert Gudbranson announced his retirement.
Read more
Imagion Biosystems names Bischoff as clinical VP
Imagion Biosystems (ASX:IBX)...
Source: Mass Device - Category: Medical Devices Authors: Brad Perriello Tags: Replacement Heart Valves Wall Street Beat 4Tech Check-Cap CHF Solutions Inc. imaginmedical imagionbiosystems Invacare LimFlow orthosalespartners personnel-moves Teleflex Source Type: news
More News: Cardiology | Gastroschisis Repair | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Ireland Health